Could ImmunoPrecise Antibodies Ltd (IPA)’s Current Volatility Hinder Its Future Potential?
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) has a beta value of 0.21 and has seen 0.41 million shares traded in the recent trading session. The company, currently